Consistent with this, we observed that an optimized local anti-tumour CD8 T cell immunity correlates with a decreased frequency of CD103+CD4+ Treg cells in anti-PD-1-treated-αV-knockout tumours. The gene discussed is CD4; the disease is neoplasm.